Panel The Big Picture Plenary Series track
Unlocking Pharma’s Productivity Potential
Mon, Nov 9, 2026 · 11:15 AM–12:00 PM CET The Big Picture Stage, Koelnmesse
About this session
The economics of pharma’s R&D model are under increasing strain. Rising costs, timelines and competition – felt across the entire industry – are offset by the outsized successes of the few winners. This plenary takes a data-led view of pharma productivity, from developing new medicines, making them available to patients, and delivering a sustainable return on investment. Over the last five years, R&D budgets are coming under increasing pressure, which raises the importance of external innovation.
Speakers
-
VP Rare Disease & Cell Therapy Business Development, Corporate Development · Novo
Panelist
